Drug tendering starts, each drug company looks at

People in the industry all know that 2014 is a big year for medicines. As the bidding work in the provinces began to advance one after another, pharmaceutical listed companies are gearing up to prepare for market expansion in the coming years. The general manager of a listed company in a listed company in Guangdong disclosed that Guangdong's base medicine supplement list has been introduced, supplemented more than 400 varieties, the first batch of tenders has been completed, the second round is beginning to apply; Zhejiang Province will announce the base medicine at the end of the month Supplementary directory. In addition, the provinces that are bidding are Jilin and Hunan. The provinces to be invited for bidding include Anhui, Sichuan, Gansu, and Yunnan.

It is reported that the list of Zhejiang JiYao supplements to be announced at the end of March may reach 360. “Adding 520 varieties of essential medicines, Zhejiang will have a total of 880 varieties of base drugs, which is quite impressive.” The above-mentioned sources said that in the face of market expansion, pharmaceutical companies are gearing up. "After entering the catalogue, it is equivalent to obtaining a market ticket, and business sales are also expected to achieve rapid increase."

It has been observed that the bidding rules vary from place to place. For example, the list of supplements in Zhejiang is divided into several parts, including recommendations recommended by the Economic and Information Committee and recommended by various prefecture-level cities. “The last adjustments or changes are mainly recommended by prefecture-level cities.” The Jiangsu-based drug bidding tone will be continued. Based on the principle of volume procurement, in early March, the Health Department of Jiangsu Province had issued “Notice on Doing a Good Job on the Basic Drug Centralized Purchasing Plan for the Primary Health Care Institutions in the Province in 2014” to the various urban public health bureaus. 2014 drug purchase plan.

According to reports, the tender for basic medicines in Shanghai has not been started yet. The bidding for medical insurance was started first, and it was completed in each district. At present, Baoshan and Yangpu have already begun preparations for bidding for Medicare drugs. The specific responsible units in each district are the district health bureaus. Shanghai's medical insurance bidding is coordinated by the Shanghai Municipal Social Security Bureau.

“Regardless of the different local rules, companies must first understand the rules of the game in order to participate in the game.” The above-mentioned sales personnel shook their heads and sighed.

There have been listed companies that have won the first prize for bidding. For example, Huahai Pharmaceuticals has won a lot in the bidding for base drugs in Guangdong. "Guangdong's 14 antihypertensive drugs accounted for 5 seats." Huahai Pharmaceutical's responsible person in charge of the tender revealed to reporters yesterday.

Yuheng Pharmaceutical Co., Ltd. stated on the interactive platform that the company's product Anman Pill won the bid in Beijing, Qinghai and Gansu provinces and cities.

In the performance briefing held recently, Tonghua Dongbao executives introduced that in the next few months, most of the provinces and cities in China will start bidding for base medicines in succession, and the company will do its utmost to prepare for bids.

It is worth noting that, although the market for the base medicine is huge, there are also price reduction expectations. For example, on March 16th, Shandong announced the second batch of bid-winning companies, among which 488 bid-winning varieties had a significant price drop compared with the national guidance price. Among them, the Yunnan Baiyao capsule (32 tablets) won the bid price of 34.71 yuan, the national guide price was 40.40 yuan; Huang Shisheng sound pill (108 pills) the bid price was 18.45 yuan, compared with other provinces, the price of base drugs fell 10%.